Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects

International Journal of Obesity

Volumn 22, Issue 9, 1998, Pages 899-905

  Haffner, S M ^a   Miettinen, H ^a   Mykkanen L ^a   Stern, M P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Insulin; Leptin; Mexican Americans; Obesity; Proinsulin

Indexed keywords

INSULIN; LEPTIN; PROINSULIN;

ADULT; AGE; ARTICLE; BODY BUILD; BODY FAT; CAUCASIAN; ETHNIC GROUP; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MEXICO; NORMAL HUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SKINFOLD THICKNESS; UNITED STATES;

PIERINAE;

EID: 0031877036     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800679     Document Type: Article

References (61)

1. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132-1143.
2. Ohlson LO, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L, Björntorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
3. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body fat distribution. Diabetes 1990; 39: 283-288.
4. Barnett AH, Eff C, Leslie RDG, Pyke DA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87-93.
5. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type II (non-insulin dependent) diabetes mellitus in male twins. Diabetologia 1987; 30: 763-768.
6. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA 1986; 256: 51-54.
7. Bouchard C, Pérusse L. Genetics of obesity. Ann Rev Nutr 1993; 13: 337-354.
8. Coleman DL. Obese and diabetes: Two mutant genes causing diabetes obesity syndromes in mice. Diabetologia 1978; 14: 141-148.
9. Friedman JM, Leibel RL, Siegel DS, Walsh J, Bahary N. Molecular mapping of mouse ob mutation. Genomics 1991; 11: 1054-1062.
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nat Med 1994; 372: 425-432.
11. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995; 44: 855-858.
12. Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (OB) gene in adipose tissue of human obese subjects. Nat Med 1995; 1: 950-953.
13. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995; 1: 953-956.
14. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995; 95: 2986-2988.
15. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
16. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161.
17. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996; 334: 292-295.
18. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and non-diabetic Mexican Americans. Diabetes 1996; 45: 822-824.
19. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, El-Towil K, Rude RK, Kamdar V. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997; 82: 579-584.
20. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W, Hauner H. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997; 100: 808-813.
21. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D. Insulin in the brain: A hormonal regulator of energy balance. Endocr Rev 1992; 13: 387-414.
22. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168-173.
23. Valdez R, Mitchell BD, Haffner SM, Hazuda HP, Morales PA, Monterrosa A, Stern MP. Predictors of weight change in a biethnic population. The San Antonio Heart Study. Int J Obes 1994; 18: 85-91.
24. Dagogo-Jack S, Fanelli C, Paramore D, Brothes J, Landt M. Plasma leptin and insulin relationships in obese and non-obese humans. Diabetes 1996; 45: 695-698.
25. Haffner SM, Miettinen H, Mykkänen L, Karhapää P, Rainwater DL, Laakso M. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes 1997; 21: 284-287.
26. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentrations in lean and obese men. Diabetes 1997; 45: 988-991.
27. Kolacznski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JR. Acute and chronic effects of insulin on leptin production in humans. Studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
28. Malmström R, Taskinen MR, Karonen SL, Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patiens with NIDDM. Diabetologia 1996; 39: 993-996.
29. Cohen B, Novick D. Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
30. Kiefer TJ, Haller RS, Habener JF. Leptin receptors expressed on pancreatic β-cells. Biochem Biophys Res Commun 1996; 224: 522-527.
31. Emilsson V, Liu VL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and directly inhibitory action of leptin on insulin secretion. Diabetes 1997; 46: 313-316.
32. Porte D. Banting Lecture 1990. β-cells in type II diabetes mellitus. Diabetes 1991; 40: 166-180.
33. Ward WK, LaCava EC, Paquette TL, Bard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987; 30: 698-702.
34. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1988; 31: 355-360.
35. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1989; i: 293-295.
36. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr. Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1990; 70: 1247-1253.
37. Reaven GM, Chen Y-DI, Hollenbeck CB, Sheu WHH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and non-obese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993; 76: 44-48.
38. Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Mykkänen L, Valdez RA, Monterrosa A, Bowsher R. Proinsulin and specific insulin concentrations in high and low risk populations for NIDDM. Diabetes 1994; 43: 1490-1493.
39. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993; 10: 313-320.
40. Haffner SM, Stern MP, Miettinen H, Gingerich R, Bowsher RR. Higher proinsulin and specific insulin are both associated with a parental history of diabetes in non-diabetic Mexican Americans subjects. Diabetes 1995; 44: 1156-1160.
41. Williams R, Byrne C, Clark PMS, Cox L, Day NE, Rayman G, Wang T, Hales CN. Raised proinsulin concentration as early indicator of B-cell dysfunction. BMJ 1991; 303: 95-96.
42. Roder ME, Eriksson J, Hartling SG, Groop L, Binder C. Proportional proinsulin responses in first-degree relatives of patients with type 2 diabetes mellitus. Acta Diabet 1993; 30: 132-137.
43. Krentz AJ, Clark PM, Cox L, Nattrass M. Hyperproinsuline-mia in impaired glucose tolerance. Clinical Science 1993; 85: 97-100.
44. Phillips DIW, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994; 11: 286-292.
45. Mykkänen L. Haffner SM, Hales CN, Rönnemaa T, Laakso M. The relation of proinsulin, insulin and proinsulin-to-insulin sensitivity and acute insulin response in normoglycemic subjects. Diabetes 1997; 46: 1990-1995.
46. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 1984; 120: 834-851.
47. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986; 315: 220-224.
48. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M. A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol 1986; 123: 96-112.
49. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991; 14: 102-108.
50. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes 1995; 44: 1386-1391.
51. World Health Organization Study Group on Diabetes Mellitus. Diabetes Mellitus: Report of a WHO Study Group. WHO: Geneva, 1985, pp 94-98 (Technical Report Series No. 727).
52. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK, Malina R. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes 1986; 10: 493-502.
53. Haffner SM, Stern MP, Miettinen H. Gingerich R, Bowsher RR. Higher proinsulin and specific insulin are both associated with a parental history of diabetes in non-diabetic Mexican American subjects. Diabetes 1995; 44: 1156-1160.
54. Bowsher RR, Wolny JD, Frank BH. A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes 1992; 41: 1084-1090.
55. Ma ZA, Gingerich RL, Santigao JV, Klein S, Smith HC, Landt M. Analyses of human plasma leptin by radioimmunoassay. Clin Chem 1996; 42: 942-946.
56. Sinha MK, Ohannesian JP, Heimen ML, Kriauciunas A, Stephens RW, Magosin S, Marco C, Caro JF. Nocturnal rise of leptin in lean, obese, and non-insulin dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-1347.
57. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. PNAS 1995; 92: 6957-6960.
58. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
59. Lindpaintner K. Clinical implications of basic research: finding an obesity gene - a tale of mice and man. N Engl J Med 1995; 332: 679-680.
60. Després J-P, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991; 54: 471-477.
61. Després J-P, Lemieux S, Lamarche B, Prud'homme D, Moorjani S, Brun L-D, Gagne C, Lupien PJ. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes 1995; 19(Supp. 1): S76-S86.